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Introduction 
The marine environment is an exceptional reservoir of bioactive 
compounds, many of which exhibit structural/chemical features not 
found in terrestrial natural products. This is easily understood since the 
Ocean, which covers almost 71% of the Earth’s surface and represents 
a uniqueness of the physical and chemical conditions, is considered 
as a very promising source of Natural Products covering a wide range 
of bioactivities [1-6]. Therefore, marine Natural Products continue to 
play a major role in drug discovery.
Since the Azorean archipelago is located in the warm temperate 
region of the North East Atlantic, approximately 1200 km from 
Europe, the marine fauna and flora of this group of islands appear to 
be a mixture of species which can be found both in the Atlantic and the 
Mediterranean [7]. Marine macroalgae are abundant and structuring 
organisms of the coastal area of the entire Azores archipelago, some 
having a markedly seasonal pattern and others being present during the 
whole year in the Azorean coasts [8-10]. The geographical distribution 
of these macroalgae is related to the temperature regime of the region 
where they grow, reproduce, and survive. However, the diversity and 
abundance of these organisms depend on many other biological factors 
[11], leading to production of different secondary metabolites of the 
species from different geographical locations [12]. Macroalgae produce 
myriads of secondary metabolites which are synthesized at the end 
of the growth phase and/or due to metabolic alterations induced by 
environmental stress conditions [13]. These metabolites have been 
targets of the drug discovery program and some of these bioactive 
compounds such as sulfated polysaccharides, steroids and diterpenes 
have found their applications in the pharmaceutical industry [14,15]. 
During our on-going project aiming at exploiting bioactive 
secondary metabolites from macroalgae of the Azorean archipelago 
for added-value products, we have conducted phytochemical studies 
of the green alga Ulva rigida C. Agardh and the red alga Gelidium 
microdon Kützing, and evaluation of the in vitro antitumor and 
antimicrobial activities of the crude extracts of these two macroalgae 
as well as their isolated metabolites. The main reasons for selection of 
these two species were based on the fact that Ulva and Gelidium species 
are well-recognized sources of industrially important biopolymers and 
the organic crude extracts of these two species had been previously 
found to exhibit a promising in vitro cytotoxicity on cancer cell lines 
and antioxidant activity [16]. Furthermore, they are abundant in the 
Azorean intertidal areas [8,17]. Although both species are locally 
abundant and dominant at the Azorean intertidal bedrock areas, U. 
rigida is common and abundant at mid and low shore levels whereas 
G. microdon is extremely abundant at mid shore level. Consequently, 
Abstract
The green macroalga Ulva rigida C. Agardh (Chlorophyta) and the red macroalga Gelidium microdon Kützing 
(Rhodophyta), collected from the Azorean archipelago, were investigated for their secondary metabolites and their in 
vitro growth inhibitory effect on three human tumor cell lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell 
lung cancer) and A375-C5 (melanoma), as well as for their antifungal and antibacterial activities. The methanol extract 
of U. rigida furnished isofucosterol (1), 7(E)-3β-hydroxy-5α,6α-epoxymegastigmane (2) and (+)-dehydrovomifoliol (3) 
while the methanol extract of G. microdon yielded cholesterol (4) and lumichrome (5). The crude extracts of both 
macroalgae were found to be moderately active against the three cell lines whereas compound 1 showed a weak effect 
and compound 2 was inactive. The crude extracts of the two macroalgae were found to be moderately active against 
some fungi and bacteria while compounds 1 and 2 were inactive against all microorganisms tested.
Citation: Silva M, Vieira LMM, Almeida AP, Silva AMS, Seca AML, et al. (2013) Chemical Study and Biological Activity Evaluation of Two Azorean 
Macroalgae: Ulva rigida and Gelidium microdon. Oceanography 1: 102. doi:10.4172/2332-2632.1000102
Page 2 of 7
Volume 1 • Issue 1 • 1000102OceanographyISSN: 2332-2632 Oceanography, an open access journal
their abundance and easy access for collection can guarantee their 
quantity for further biotechnological exploitation in the future. 
Furthermore, as these two species are annual and intertidal, they do 
not present any significant variations of the concentrations of their 
secondary metabolites, which can be influenced by their age and 
depth of the collection site. Although both Ulva and Gelidium species 
have been extensively investigated as sources of biotechnologically 
relevant biopolymers, their secondary metabolites have never been 
fully exploited for value-added products. While Ulva species are an 
important source of ulvan, a natural sulfated polysaccharide which 
has been extensively investigated for development of novel drugs and 
functional foods [18], Gelidium species are one of the main sources 
of phycocolloids, such as agar [19,20]. Several types of secondary 
metabolites such as bromophenol [21-23], sesquiterpenes [24,25], and 
steroids [23,26] have been previously reported from the macroalgae of 
the genus Ulva; however, there are only few reports on the chemical 
constituents of the genus Gelidium. While gelidene, a polyhalogenated 
monocyclic monoterpene, was isolated from G. sesquipedale [27], 
jasmonic acid was reported from G. latifolium [28].
Due to the pristine environment of the Azorean archipelago, 
we have elaborated the project aiming to exploit the potential of the 
macroalgae of this region. The collections of these two species were 
carried out in May and October in order to allow us to study their 
chemical compositions in different seasons, i.e. spring and autumn, 
as well as of two different reproductive stages. We now report the 
chemical study together with the antitumor and antimicrobial activities 
evaluation of the first collection (May 2011) of the green macroalga 
U. rigida and the red macroalga G. microdon from S. Miguel Island 
which is considered to be one of the environmentally healthy habitats 
and rich in algal communities of the Azorean Sea. Examination of the 
methanol extract of U. rigida led to isolation of isofucosterol (1), 7(E)-
3β-hydroxy-5α,6α-epoxymegastigmane (2) and (+)-dehydrovomifoliol 
(3), while the methanol extract of G. microdon yielded cholesterol 
(4) and lumichrome (5) (Figure 1). The crude extracts of both 
macroalgae, together with isofucosterol (1) and 7(E)-3β-hydroxy-
5α,6α-epoxymegastigmane (2), were evaluated for their in vitro growth 
inhibition on three tumor cell lines: MCF-7, NCI-H460 and A375-C5, 
as well as for their antifungal and antibacterial activities. 
Material and Methods 
General experimental procedures
Melting points were determined on a Bock monoscope and 
are uncorrected. Optical rotations were determined on an ADP410 
Polarimeter. 1H and 13C NMR spectra were recorded at ambient 
temperature on a Bruker Advance instrument operating at 300.13 
and 75.4 MHz, respectively. High resolution mass spectra were 
measured with a Waters Xevo QToF mass spectrometer coupled to 
a Waters Aquity UPLC system. A Merck silica gel GF 254 was used 
for preparative TLC, and a Merck Si gel 60 (0.2-0.5 mm) was used for 
analytical chromatography.
Biological material 
U. rigida and G. microdon were collected in May 2011 from the 
Figure 1: Structures of isofucosterol (1), 7(E)-3β-hydroxy-5α,6α-epoxymegastigmane (2) and (+)-dehydrovomifoliol (3), isolated from Ulva rigida and cholesterol (4) 
and lumichrome (5), isolated from Gelidium microdon.
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coast of S. Miguel island - Azores archipelago, and the samples of both 
macroalgae were deposited at the Department of Biology of University 
of Azores (Vouchers: SMG-11-49 and SMG-11-30, respectively). 
Extraction and isolation of the constituents 
Dried powdered material (U. rigida - 1472.5 g and G. microdon 
- 1293.4 g) was percolated with MeOH, at room temperature until 
exhaustion. The resulting solutions were filtered with filter paper 
(Whatman no 1) and concentrated under reduced pressure to yield 
crude extracts of U. rigida (154.49 g) and G. microdon (151.91 g). 
Treatment of the crude methanol extracts to remove the chlorophylls 
[29], furnished 14.22 g of U. rigida and 4.74 g of G. microdon purified 
extracts.                  
U. rigida - The purified extract (14.22 g) was chromatographed 
over a 0.2-0.5 mm Si Gel column (180 g) and eluted with mixtures of 
petroleum ether, CHCl3 and Me2CO, wherein 250 ml fractions were 
collected as follows: frs 1-2 (petroleum ether-CHCl3, 9:1), frs 3-52 
(petroleum ether/CHCl3, 4:1), frs 53-112 (petroleum ether-CHCl3, 1:1), 
frs 113-126 (petroleum ether-CHCl3, 1:4), frs 127-145 (CHCl3), frs 146-
167 (CHCl3-Me2CO, 9:1), frs 168-211 (CHCl3-Me2CO, 4:1), frs 212-243 
(CHCl3-Me2CO, 1:1), frs 244-289 (CHCl3-Me2CO, 1:4), frs 290-303 
(Me2CO). Frs 30 and 31 were combined (691.1 mg) and recrystallized 
in petroleum ether to give 32.0 mg of compound 1. Frs 93-106 were 
combined (121.9 mg) and purified by TLC (Si Gel, CHCl3-EtOAc-
petroleum ether-HCO2H; 3:1:1:0.01), to yield compound 2 (10.8 mg) 
and a mixture (4.6 mg) containing compound 3 as a major component.
G. microdon - The purified extract (4.74 g) was chromatographed 
over a 0.2-0.5 mm Si Gel column (120 g) and eluted with mixtures of 
petroleum ether, CHCl3, Me2CO and MeOH, 250 ml fractions were 
collected as follows: frs 1-23 (petroleum ether-CHCl3, 4:1), frs 24-73 
(petroleum ether-CHCl3, 3:2), frs 74-112 (petroleum ether-CHCl3, 
1:4), frs 113-125 (petroleum ether-CHCl3, 1:9), frs 126-142 (CHCl3), 
frs 143-175 (CHCl3-Me2CO, 9:1), frs 176-200 (CHCl3-Me2CO, 7:3), frs 
201-231 (CHCl3-Me2CO, 1:1), frs 232-236 (CHCl3-Me2CO, 3:7), frs 
237-256 (CHCl3-MeOH, 9:1), frs 257-267 (CHCl3-MeOH, 4:1), frs 268-
280 (CHCl3-MeOH, 1:1), frs  281-294 (CHCl3-MeOH, 3:7), frs 295-300 
(MeOH). Frs 11-22 were combined (665.4 mg) and purified by TLC (Si 
gel, CHCl3-toluene-HCO2H, 7:3:0.1) to give 66.9 mg of cholesterol (4) 
[30]. Frs 81-100 were combined (127.6 mg) and recrystallized in CHCl3 
to yield 2.7 mg of lumichrome (5).
Isofucosterol (1): White crystals; mp. 129-131ºC. 25[ ]Dα = - 36.2º (c 
0.083 g mL-1, CHCl3) Lit: mp 128-130ºC. 
25[ ]Dα  = - 36.8º (c 0.02 g mL-1, 
CHCl3) [31]. 1H- NMR (300 MHz, CDCl3) δ  in ppm: 5.35 dd (J=1.7, 4.4 
Hz, H-6), 5.10 q (J=6.8 Hz, H-28), 3.52 dddd (J=1.2, 5.6, 10.7, 10.7 Hz, 
H-3), 2.83 m (H-25), 2.29 m (H-4), 1.9-2.1 m (H-7, H-8, H-12, H-23), 
1.7-1.9 m (H-1, H-2, H-16, H-23), 1.4-1.6 m (H-7, H-8, H-11, H-15, 
H-20, H-22), 0.9-1.3 m (H-9, H-12, H-14, H-15, H-16, H-17, H-22), 
1.59 d (J=6.8 Hz, H-29), 1.01 s (H-19), 0.95 d (J=6.6 Hz, H-21), 0.98 d 
(J=6.9 Hz, H-26, H-27), 0.68 s (H-18). 13C-NMR (75 MHz, CDCl3) δ  in 
ppm: 145.9 s (C-24), 140.7 s (C-5), 121.7 d (C-6), 116.4 d (C-28), 71.8 
d (C-3), 56.7 d (C-14), 56.0 d (C-17), 50.1 d (C-9), 42.3 s (C-13), 42.3 t 
(C-4), 39.8 t (C-12), 37.2 t (C-1), 36.5 s (C-10), 36.1 (C-20), 35.9 (C-22), 
32.0 t (C-7), 31.9 d (C-8), 31.6 t (C-2), 28.6 d (C-25), 28.2 t (C-16), 27.9 
t (C-23), 24.3 t (C-15), 21.2 t (C-11), 21.1 q (C-26), 21.0 q (C-27), 19.4 
q (C-19), 18.8 q (C-21), 12.8 q (C-29), 11.8 q (C-18).
7(E)-3β-Hydroxy-5α, 6α-epoxymegastigmane (2): Oil; 25[ ]Dα  = - 
38.5º (c 0.026 g mL-1, CHCl3) Lit: 
25[ ]Dα = -43.7º (c 0.39 g mL-1, CH2Cl2) 
[32]. 1H and 13C NMR (Table 1).
(+)-Dehydrovomifoliol (3): White amorphous powder. 1H and 13C 
NMR (Table 2).
Cholesterol (4): White crystals; mp. 146-147ºC; 1H NMR (300 
MHz, CDCl3) δ  5.36 d (J=5.2 Hz, H-5), 3.53 m (H-3), 2.2-2.4 m (H-4 
and H-13), 1.9-2.1 m (H-7, H-12) 1.4-1.6 m (H-1 and H-2), 1.02 s (H-
19, 3H), 0.92 d (J=6.5 Hz, H-21, 3H), 0.88 d (J=6.6 Hz, H-27, 3H), 0.87 
d (J=6.6 Hz, H-27, 3H), 0.69 s (H-18, 3H); 13C-NMR (75 MHz, CDCl3) 
δ  140.7 s (C-5), 121.7 d (C-6), 71.8 d (C-3), 56.8 d (C-17), 56.1 s (C-14), 
50.1 d (C-9), 42.3 t (C-4 and C-13), 39.8 t (C-12), 39.5 t (C-24), 37.2 t 
(C-1), 36.5 s (C-10), 36.2 t (C-22), 35.8 d (C-20), 31.9 t (C-7), 31.9 t (C-
8), 31.7 t (C-2), 28.2 t (C-16), 28.0 d (C-25) 24.3 t (C-15), 23.8 t (C-23), 
22,8 q (C-27), 22.6 q (C-26), 21.1 t (C-11), 19.4 q (C-19), 18.7 q (C-21), 
11.9 q (C-18).
Lumichrome (5): Green amorphous powder. HR-ESIMS m/z 
243.0918 [M+H]+ (calcd for C12H11N4O2 , 243.0882); 1H and 13C NMR 
(Table 3).
Growth inhibition of human tumor cell lines
The effect of the extracts and of compounds 1 and 2 were evaluated 
for their capacity to inhibit in vitro growth of three human tumor cell 
lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung 
cancer) and A375-C5 (melanoma), according to the procedure adopted 
by the National Cancer Institute (NCI) in the “In vitro Anticancer 
Drug Discovery Screen” that uses the protein-binding dye SRB to 
Position δC, type δH, (J in Hz) COSY HMBC
1 35.1, C
2α 46.6, CH2 1.64, dt (12.9, 1.8) H-2β
β 1.26, dt (12.9, 10.4) H-2α
3 64.0, CH 3.90, m
4α 40.5, CH2 2.39, ddd (14.5, 5.1, 1.7) H-2β C-3, 5, 6
β 1.66, dd (14.5, 8.7) H-2α C-2, 5
5 67.3, C
6 69.4, C
7 142.4, CH 7.03, d (15.6) H-8 C-6, 8, 9
8 132.6, CH 6.29, d (15.6) H-7 C-6, 7, 9
9 197.5, CO
10 28.3, CH3 2.28, s
11 19.8, CH3 1.19, s C-4, 6
12 25.0, CH3 0.98, s C-1, 2, 6, 13
13 29.3, CH3 1.19, s C-1, 2, 6, 12
Table 1: NMR data for compound 2 in CDCl3 (1H 300.13, 13C 75.47 MHz).
Position δC, type δH, (J in Hz) COSY HMBC
1 41.4, C
2α 49.5, CH2 2.51, d (17.0) H-2 β C-1, 3, 11
β 2.34, d (17.0) H-2 α
3 197.0, CO
4 127.8, CH 5.96, brt (1.0) H-2 β, 13 C-2, 6, 13
5 160.4, C
6 79.3, C
7 145.0, CH 6.84, d (15.7) H-8 C-5, 6, 9
8 130.3, CH 6.47, d (15.7) H-7 C-6, 9
9 197.4, CO
10 28.4, CH3 2.31, s C-8, 9
11 18.7, CH3 1.88, s C-4, 5, 6
12 24.3, CH3 1.03, s C-1, 2, 13
13 22.9, CH3 1.11, s C-1, 2, 12
Table 2: NMR data for compound 3 in CDCl3 (1H 300.13, 13C 75.47 MHz).
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assess cell growth as previously described [33]. The cell cultures used 
were from different sources. MCF-7 and A375-C5 were obtained from 
the European Collection of Cell Cultures (ECACC) while NCI-H460 
was provided by the NCI collection of cell lines. Briefly, compounds 1, 
2 and the crude extracts were aseptically dissolved in DMSO and stored 
at -20°C. Appropriate dilutions of the compounds and extracts were 
freshly prepared just prior the assay and diluted with growth medium. 
Final concentrations of DMSO did not interfere with the growth of 
cell lines. Cells growing as monolayer, were routinely maintained 
in RPMI-1640 medium containing 5% FBS, at 37ºC in a humidified 
atmosphere containing 5% CO2. For the assays, each cell line was 
plated at an appropriate density (5x104 cells/mL) in 96 well-plates. 
Cells were incubated for 24h in the humidified incubator, allowing 
them to stabilize and adhere. Cells were then exposed for 48h at 37ºC 
and 5% CO2 to serial concentrations of compounds, extracts and the 
positive control, doxorubicin. Following this exposure period, cells 
were fixed in situ with 50% Trichloroacetic Acid (TCA), washed with 
distillated water and dyed with SRB. In order to solubilize protein/SRB 
complexes, Tris buffer were added to each well and absorbance (Abs 
at 515 nm) was determined in a plate reader (Biotek Synergy 2). Abs 
values were retrieved using Gene5software (Biotek). For each cell line 
a dose-response curve was obtained and the growth inhibition of 50% 
(GI50) corresponding to the concentration of compounds and extracts 
that inhibited 50% of the net cell growth was calculated according to 
the procedure adopted by the NCI. 
Antifungal assays
Broth microdilution methods based on Clinical and Laboratory 
Standards Institute (CLSI) reference protocols M27-A3 and M38-A2 
for yeasts (Candida albicans) and filamentous fungi (Aspergillus 
fumigatus and dermatophytes), respectively, were used to determine the 
MIC and MLC of the crude extracts and the isolated metabolites [34]. 
Candida albicans ATCC 10231, Aspergillus fumigatus ATCC 46645 and 
dermatophytes: Epidermophyton floccosum FF9, Microsporum canis 
FF1, Microsporum gypseum FF3, Trichophyton mentagrophytes FF7, 
and Trichophyton rubrum FF5 were used as test organisms. The yeast 
cell suspensions were prepared in 0.85% NaCl and the transmittance 
of cell density adjusted to that produced by a 0.5 McFarland standard 
for C. albicans. To achieve an inoculum size of 1-5×103 CFU/mL for 
C. albicans, the cell suspension was diluted with RPMI 1640. For 
filamentous fungi, the spore suspensions were prepared in 0.85% 
NaCl with Tween 20 and the cell density adjusted at 20-250 conidia/
square (hemocytometer) for A. fumigatus and 20-60 conidia/square 
for dermatophytes. To achieve an inoculum size of 0.4-5×104 CFU/mL 
for A. fumigatus and 1-3×103 CFU/mL for dermatophytes, the spore 
suspensions were diluted with RPMI 1640. The solutions of the extracts 
and compounds 1 and 2 were prepared in DMSO and added to the cell 
suspensions in order to obtain test concentrations ranging from 16 to 
256 µg/mL. In addition, reference antifungal compound, fluconazole 
was used as standard antifungal drug. Controls without crude extracts 
and isolated compounds, as well as sterility and DMSO control wells, 
were also included. The plates were incubated aerobically at 35ºC 
± 0.2ºC for 24h/48h in atmospheric humidity (C. albicans and A. 
fumigatus) and at 25ºC ± 0.2ºC for 5 days in atmospheric humidity for 
dermatophytes. To evaluate the MLCs, 20 µL samples were taken from 
each negative well and the first well exhibiting growth (serve as a growth 
control), after MIC reading, spotted onto SDA (Sabouraud Dextrose 
Agar) plates and incubated at 35ºC ± 0.2ºC 24h/48h (C. albicans and A. 
fumigatus) or at 25oC ± 0.2ºC for 7 days (dermatophytes). 
Antibacterial assays
A broth microdilution method, based on CLSI reference protocol 
M7-A7, was used to determine the MIC and MLC of the crude extracts 
and the isolated metabolites [35]. Escherichia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 
25923, and Methicillin Resistant Staphylococcus aureus (MRSA), 
clinical isolate, were used as test organisms.  The cell suspensions 
were prepared in 0.85% NaCl and the transmittance of cell density 
adjusted to that produced by a 0.5 McFarland standard. To achieve an 
inoculum size of 105 CFU/mL, the cell suspensions were diluted with 
MHB (Muller-Hinton Broth). The stock solutions of the extracts, and 
compounds 1 and 2 were prepared in DMSO and further diluted in 
serial two-folds with MHB to final concentrations ranging from 16 to 
256 µg/mL. In addition, gentamicin was used as standard antibacterial 
drug and controls without crude extracts and isolated compounds, as 
well as sterility and DMSO control wells, were also included. The plates 
were incubated aerobically at 35ºC ± 0.2ºC for 16h/20h in atmospheric 
humidity. To measure the MLCs, 20 µL samples were taken from each 
negative well and the first well exhibiting growth (serve as a growth 
control), after MIC reading, spotted onto MHA (Muller-Hinton Agar) 
plates and incubated at 35ºC ± 0.2ºC for 24h. 
Results and Discussion
The structures of the compounds were established mainly by 1D (1H 
and 13C NMR) and 2D (COSY, DEPT, HSQC and HMBC experiments) 
spectroscopic techniques as well as comparison of their NMR data with 
those reported in the literature.
Compound 1 was isolated as white crystals with mp 129-131oC. The 
13C NMR, DEPT and HSQC spectra revealed the presence of twenty 
nine carbon signals which can be categorized as two quaternary sp2 
(δc 145.9, 140.7), two methine sp2 (δc 121.7, 116.4), two quaternary 
sp3 (δc 42.3, 36.5), one oxymethine sp3 (δc 71.8), six methine sp3 (δc 
56.7, 56.0, 50.1, 36.1, 31.9, 28.6), ten methylene sp3 (δc 42.3, 39.8, 37.2, 
35.9, 31.9, 31.6, 28.2, 27.9, 24.3, 21.1) and six methyl (δc 21.1, 21.0, 
19.4, 18.8, 12.8, 11.8) carbons. The HMBC correlations of H-6 (δH 5.35, 
dd, J= 4.4, 1.7, δc 121.7) to C-4 (δc 42.3), C-8 (δc 31.9), C-10 (δc 36.5) 
revealed the presence of a trisubstituted double bond between C-5 and 
C-6. That another trisubstituted double bond was on C-24 and C-28 
was corroborated by the HMBC correlations of H-28 (δH 5.10, q, J = 6.8, 
δc 116.4) to C-25 (δc 28.6) and C-29 (δc 12.8). The coupling constants 
of H-3 suggested that the C-3 hydroxyl group was β. The 1H and 13C 
Position δC, type δH, (J in Hz) HMBC
1
2 130.2, C
3 146.5, C
4
5 138.4, C
6 128.7, CH 7.92, s C-7, 13, 15
7 138.9, C
8 144.7, C
9 125.8, CH 7.71, s C-6, 12, 16
10 141.6, C
11 11.84, brs C-2
12 150.1, CO
13 11.68, brs C-2
14 160.7, CO
15 19.6, CH3 2.47, s C-11, 12, 13
16 20.2, CH3 2.49, s C-9, 12, 13
Table 3: NMR data for compound 5 in CDCl3 (1H 300.13, 13C 75.47 MHz).
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chemical shift values of compound 1 were compatible with those of 
isofucosterol [36,37]. Isofucosterol is a common phycosterol and it has 
been previously reported from several macroalgae [38].
The 13C NMR spectrum of compound 2 displayed thirteen carbon 
signals which were categorized, by DEPT and HSQC experiments 
(Table 1), as one carbonyl of a conjugated ketone (δc 197.5), two 
methine sp2 (δc 132.6, 142.4), two oxyquaternary sp3 (δc 69.4, 67.3), one 
quaternary sp3 (δc 35.1), one oxymethine sp3 (δc 64.0), two methylene 
sp3 (δc 40.5, 46.6) and four methyl (δc 19.8, 24.9, 28.3, 29.3) carbons. The 
COSY spectrum displayed cross peak between the olefinic protons at δH 
7.03 d (J= 15.6) and δH 6.29 d (J= 15.6), confirming the presence of a 
trans double bond. That this trans double bond was part of the 3-oxo-
butenyl side chain which linked to C-6 of the cyclohexanol moiety was 
supported by the HMBC correlations of the methyl protons signal at 
δH 2.28s (δC 28.3) to the carbon signals at δC 132.6 (C-8), δC 142.4 (C-7) 
and δC 197.5 (C-9), as well as of the proton signal at δH 6.29d, J = 15.6 
(δC 132.6) to the carbon signals at δC 197.5 (C-9) , δC 142.4 (C-7), δC 69.4 
(C-6). As the proton signals of the methyl groups at δH 0.98 (δC 25.0) 
and δH 1.19s (δC 29.3) gave cross peaks to the quaternary carbon signal 
at δC 35.1 (C-1) as well as to the carbon signals at δC 46.6 (C-2) and δC 
69.4 (C-6), they were assigned for C-12 and C-13, respectively. These 
correlations led to the conclusion that the structure of compound 2 
should correspond to 7(E)-3β-hydroxy-5, 6-epoxymegastigmane. As 
compound 2 is levorotatory with 25[ ]Dα = -38.5º, it was identified as 
7(E)-3β-hydroxy-5α, 6α-epoxymegastigmane. The 1H and 13C NMR 
data of compound 2 were compatible with those of (3S, 5R, 6S, 7E)-
5, 6-epoxy-3-hydroxy-7-megastigmen-9-one, previously isolated from 
the solanaceous plant Cestrum parqui L’ Hérit [32].
Compound 3 was isolated as a mixture, as was evidenced by its 1H 
NMR spectrum. Through the HMBC correlations, two sets of carbon 
signals could be discerned in the 13C NMR spectrum of the mixture 
(Table 2). The first set of the carbon signals, belonging to compound 
3, comprised of thirteen carbon signals which were identified by DEPT 
and HSQC as two carbonyls (δC 197.4 and δC 197.0), one quaternary sp2 
(δC 160.4), three methine sp2 (δC 127.8, 130.3, 145.0), one oxyquaternary 
sp3 (δC 79.3), one quaternary sp3 (δC 41.2), one methylene (δC 49.5), and 
four methyl (δC 18.7, 22.9, 24.3, 28.4) carbons.  Similar to compound 2, 
there was a 3-oxo-butenyl side chain which linked to the cyclohexenone 
moiety through the oxyquaternary sp3 carbon at δC 79.3, as was 
evidenced by the HMBC correlations of the methyl proton signal at δC 
2.31s (CH3-10) to C-8 (δC 130.3) and C-9 (δC 197.4), as well as of H-8 
signal (δH  6.47, d, J = 15.7 Hz) to C-9 (δC 197.4) and C-6 (δC 79.3). The 
presence of the 3,5,5-trimethyl-4-hydroxy-2-cyclohexenone moiety 
was confirmed by the HMBC correlations of the olefinic proton signal 
at δH 5.96, brt, J = 1.0 Hz (δC 127.8) to CH3-11 (δC 18.7), C-2 (δC 49.5), 
C-6 (δC 79.3), as well as of the methyl proton signals at δH 1.03s (δH 
24.3, CH3-12) and δH 1.11s (δH 22.9, CH3-13) to C-1 (δC 41.2), C-2 (δC 
49.5) and C-6 (δC 79.3). The structure of compound 3 was established as 
(+)-dehydrovomifoliol, previously isolated from several plant sources 
[39]. However, due to the small quantity of the mixture isolated, it was 
not possible to isolate 3 as a pure compound to determine its optical 
rotation.
Compound 5 was isolated as green amorphous powder and its 
molecular formula C12H10N4O2 was established on the basis of the 
(+)-HR-ESIMS m/z 243.0918 [M+H]+ (calcd 243.0882), indicating ten 
degrees of unsaturation. The 13C NMR, DEPT and HSQC spectra (Table 
3) revealed the presence of two amide carbonyls (δC 160.7, 150.1), six 
quaternary sp2 (δC 130.2, 138.4, 138.9, 141.6, 144.7, 146.5), two methine 
sp2 (δC 125.8, 128.7) and two methyl (δC 19.6, 20.2) carbons. The HMBC 
spectrum displayed cross peaks of the amide proton signals at δH 
11.7s (NH-13) and δH 11.8s (NH-11) to the carbon signal at δC 130.2 
(C-2). While the proton signal at δH 7.92s (δC 128.7) showed HMBC 
correlations to C-8 (δC 144.7), C-10 (δC 141.6) and CH3-15 (δC 19.6), 
the proton signal at δH 7.71s (δC 125.9) showed HMBC correlations to 
C-5 (δC 138.4), C-7 (δC 138.9) and CH3-16 (δC 20.2). Thus, the structure 
of compound 5 is 7, 8-dimethylalloxazine or commonly known as 
lumichrome. Lumichrome, a derivative of the vitamin riboflavin, has 
been purified and chemically identified from culture filtrates of the alga 
Chlamydomonas as a Quorum Sensing (QS) signal-mimic compound 
capable of stimulating the Pseudomonas aeruginosa LasR QS receptor 
[40]. Bacteria, plants, and algae commonly secrete riboflavin or 
lumichrome, raising the possibility that these compounds could serve 
as either QS signals or as interkingdom signal mimics capable of 
manipulating QS in bacteria with a LasR-like receptor [40].
The effect of the extracts of U. rigida and G. microdon (before 
and after removal of the chlorophylls), isofucosterol (1) and 7(E)-
3β-hydroxy-5α,  6α-epoxymegastigmane (2) were evaluated for 
their capacity to inhibit in vitro growth of three tumor cell lines: 
MCF-7, NCI-H460 and A375-C5. The results showed that the crude 
extracts were moderately active against the three cell lines; however, 
isofucosterol (1) was found to be less active than the crude extract of 
U. rigida, while 7(E)-3β-hydroxy-5α,6α-epoxymegastigmane (2) was 
inactive (Table 4).
The crude methanol extracts of U. rigida and G. microdon (before 
and after removal of the chlorophylls) were also evaluated for their 
antifungal activity against C. albicans, A. fumigatus, and dermatophytes 
E. floccosum, M. canis, M. gypseum, T. mentagrophytes, and T. rubrum. 
The results showed that removal of the chlorophylls caused an increase 
in antifungal activity of U. rigida against T. rubrum, T. mentagrophytes, 
M. canis, and E. floccosum. Whereas T. rubrum showed higher 
susceptibility, M. gypseum showed more resistance (MIC higher than 
256 µg/mL). Removal of the chlorophylls also caused an increase in 
the activity of G. microdon crude extract against T. rubrum and E. 
floccosum. It was found that M. canis showed more susceptibility 
while T. mentagrophytes and M. gypseum showed higher resistance. 
Interestingly, both isofucosterol (1) and 7(E)-3β-hydroxy-5α,6α-
epoxymegastigmane (2) were inactive against all the tested organisms 
(Table 5). 
Extract/Compounds Cell lines / GI50 (µg/ml)
MCF-7 NCI-H460 A375-C5
U. rigida (before removal of 
chlorophylls) 44.5 ± 18.4 49.1 ± 14.0 40.8 ± 10.2
U. rigida (after removal of chlorophylls) 43.0 ± 10.3 41.9 ± 12.1 44.5 ± 7.6
G. microdon (before removal of 
chlorophylls) 75.9 ± 16.1 70.6 ± 20.1 36.3 ± 8.0
G. microdon (after removal of 
chlorophylls) 63.1 ± 14.1 64.9 ± 16.6 62.6 ± 15.9
                                                             Cell lines / GI50 (µM)
MCF-7 NCI-H460 A375-C5
1 122.2 ± 17.9 128.4 ± 32.4 119.2 ± 28.9
2 ≥ 200 ≥ 200 ≥ 200
*Results are given as the lowest concentrations causing 50% of cell growth 
inhibition (GI50) after a continuous exposure to the compounds for 48 hours and 
are expressed as means ± SEM of three independent experiments performed in 
triplicate. Doxorubicin was used as positive control, GI50: MCF-7 = 60.3 ± 1.2 nM; 
NCI-H460 = 19.6 ± 1.9 nM; A375-C5 = 130 ± 25.2 nM.
Table 4: Growth inhibitory effect of crude methanol extracts of U. rigida and G. 
microdon, compounds 1 and 2, in different cell lines*.
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The extracts of U. rigida and G. microdon (before and after removal 
of the chlorophylls) were evaluated for their activity against E. coli, P. 
aeruginosa, S. aureus, and MRSA. The results (Table 6) showed that the 
crude methanol extract of U. rigida (before and after removal of the 
chlorophylls) did not show any antibacterial activity against E. coli, P. 
aeruginosa and S. aureus, however removal of the chlorophylls caused 
a weak activity against MRSA. Similarly, the crude methanol extract of 
G. microdon did not show any activity against the test bacteria; however 
removal of the chlorophylls showed a weak activity against S. aureus 
and that sensitivity increases against MRSA. Interestingly, neither 
isofucosterol (1) nor 7(E)-3β-hydroxy-5α,6α-epoxymegastigmane (2) 
showed activity against all the strains of tested organisms (Table 6).
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